Dear Supporters,
I’m writing to share some exciting developments regarding our petition urging CVS Caremark to keep Zepbound on their formulary. First and foremost, thank you. I am truly amazed by the passion, advocacy, and united voice of this incredible community of patients and providers. Your support is making a real impact. In less than three days, we have over 2,250 signatures.
We’ve seen fantastic momentum, and our collective message is starting to break through:
- Media Coverage: I’m pleased to share that Bloomberg News published an article today discussing this critical issue and even mentioned our petition directly! This is a significant step in raising broader public awareness. You can read the article here: https://www.bloomberg.com/news/articles/2025-05-09/zepbound-patients-fear-switch-to-wegovy-after-cvs-deal
- Spreading the Word: I also recently had the opportunity to discuss the CVS Caremark decision and our petition on the Gaining Health Podcast with Karli Burridge, PA-C. I also detailed the issue in an interview on The Downsized YouTube channel. Both episodes will be airing soon in the coming weeks.
- Growing Support: The sheer number of signatures and heartfelt comments on the petition in such a short time speaks volumes!
Our collective voice is powerful, and it's crucial we keep advocating. Please continue to share the petition with your networks – friends, family, colleagues, and on social media using #KeepZepbound. Every share helps reach more people who care about patient access to the best possible obesity treatments. Also, please continue posting your personal stories on the petition comment section to showcase how Zepbound has impacted you or your patients’ health.
Petition Link: https://www.change.org/p/stop-cvs-caremark-s-zepbound-ban-restore-coverage-of-the-superior-obesity-medication
What’s Next?
This is just the beginning. I am committed to ensuring our concerns are heard directly by those making these decisions. I will be compiling all of this incredible support – the petition signatures, your powerful comments, and the media attention – and will formally submit it to the President, Vice President, and Chief Medical Officer at CVS Caremark, as well as other key members of their team.
My goal is to help them understand the profound impact this formulary change will have on patients' lives and their health journeys.
Thank you again for your unwavering support and for lending your voice to this critical cause. I truly believe that by standing together and advocating effectively, we can make a difference. I will continue to fight on behalf of my patients and everyone affected by this decision.
Sincerely,
Joseph Zucchi, PA-C, MPAS, CPT
Clinical Supervisor
Transition Medical Weight Loss